239 related articles for article (PubMed ID: 21431619)
1. Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I.
Guillard M; Wada Y; Hansikova H; Yuasa I; Vesela K; Ondruskova N; Kadoya M; Janssen A; Van den Heuvel LP; Morava E; Zeman J; Wevers RA; Lefeber DJ
J Inherit Metab Dis; 2011 Aug; 34(4):901-6. PubMed ID: 21431619
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.
Babovic-Vuksanovic D; O'Brien JF
Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418
[TBL] [Abstract][Full Text] [Related]
3. Transferrin variants: pitfalls in the diagnostics of Congenital disorders of glycosylation.
Zühlsdorf A; Park JH; Wada Y; Rust S; Reunert J; DuChesne I; Grüneberg M; Marquardt T
Clin Biochem; 2015 Jan; 48(1-2):11-3. PubMed ID: 25305627
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry of transferrin glycoforms to detect congenital disorders of glycosylation: Site-specific profiles and pitfalls.
Wada Y
Proteomics; 2016 Dec; 16(24):3105-3110. PubMed ID: 27095603
[TBL] [Abstract][Full Text] [Related]
5. The novel transferrin E592A variant impairs the diagnostics of congenital disorders of glycosylation.
Park JH; Zühlsdorf A; Wada Y; Roll C; Rust S; Du Chesne I; Grüneberg M; Reunert J; Marquardt T
Clin Chim Acta; 2014 Sep; 436():135-9. PubMed ID: 24875750
[TBL] [Abstract][Full Text] [Related]
6. Congenital disorders of glycosylation.
Jaeken J
Ann N Y Acad Sci; 2010 Dec; 1214():190-8. PubMed ID: 21175687
[TBL] [Abstract][Full Text] [Related]
7. The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation.
Sturiale L; Barone R; Garozzo D
J Inherit Metab Dis; 2011 Aug; 34(4):891-9. PubMed ID: 21384227
[TBL] [Abstract][Full Text] [Related]
8. Secondary disorders of glycosylation in inborn errors of fructose metabolism.
Quintana E; Sturiale L; Montero R; Andrade F; Fernandez C; Couce ML; Barone R; Aldamiz-Echevarria L; Ribes A; Artuch R; Briones P
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S273-8. PubMed ID: 19768653
[TBL] [Abstract][Full Text] [Related]
9. A new method for the rapid diagnosis of protein N-linked congenital disorders of glycosylation.
Heywood WE; Mills P; Grunewald S; Worthington V; Jaeken J; Carreno G; Lemonde H; Clayton PT; Mills K
J Proteome Res; 2013 Jul; 12(7):3471-9. PubMed ID: 23742123
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation.
Wada Y
Glycoconj J; 2016 Jun; 33(3):297-307. PubMed ID: 26873821
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
[TBL] [Abstract][Full Text] [Related]
12. "Hide and seek": Misleading transferrin variants in PMM2-CDG complicate diagnostics.
Raynor A; Bruneel A; Vermeersch P; Cholet S; Friedrich S; Eckenweiler M; Schumann A; Hengst S; Tuncel AT; Fenaille F; Thiel C; Rymen D
Proteomics Clin Appl; 2024 Mar; 18(2):e2300040. PubMed ID: 37876147
[TBL] [Abstract][Full Text] [Related]
13. Fast screening of N-glycosylation disorders by sialotransferrin profiling with capillary zone electrophoresis.
Kingma HA; van der Sluijs FH; Heiner-Fokkema MR
Ann Clin Biochem; 2018 Nov; 55(6):693-701. PubMed ID: 29792046
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
[TBL] [Abstract][Full Text] [Related]
15. Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease.
Pérez-Cerdá C; Quelhas D; Vega AI; Ecay J; Vilarinho L; Ugarte M
Clin Chem; 2008 Jan; 54(1):93-100. PubMed ID: 18024528
[TBL] [Abstract][Full Text] [Related]
16. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
18. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
[TBL] [Abstract][Full Text] [Related]
19. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.
van Scherpenzeel M; Steenbergen G; Morava E; Wevers RA; Lefeber DJ
Transl Res; 2015 Dec; 166(6):639-649.e1. PubMed ID: 26307094
[TBL] [Abstract][Full Text] [Related]
20. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
